Allogene Therapeutics, Inc. (ALLO)

Import this data to Google Sheets with:

=jivedata("ALLO","financials")

Full statements spill as a table. For one cell: =jivedata("ALLO","Revenue") or =jivedata("ALLO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Allogene Therapeutics, Inc.

ALLO • CIK 0001737287

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$95	$22	$0	$4,640
Operating Income (Loss)	$-327,737	$-273,199	$-209,315	$-180,317
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	$-257,147	$-190,886	$-190,886
Income Tax Expense (Benefit)	$0	$443	$0	$0
Net Income (Loss) Attributable to Parent	$-1,562,200	$-257,590	$-190,886	$-165,494
Weighted Average Number of Shares Outstanding, Basic	156,931,778	194,811,756	220,622,669	288,324,107
Research and Development Expense	$242,914	$192,299	$150,152	$122,520
General and Administrative Expense	$71,673	$65,205	$56,781	$62,437
Impairment of Long-Lived Assets Held-for-use	$13,245	$15,717	$2,382	$0
Operating Expenses	$327,832	$273,221	$209,315	$184,957
Interest and Other Income	$18,307	$20,153	$19,289	$15,806
InterestExpenseNonoperating	—	$181	$1,075	$1,300
Other Nonoperating Income (Expense)	$-17,835	$-3,920	$215	$317
Nonoperating Income (Expense)	$472	$16,052	$18,429	$14,823
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax	$8,971	$866	$358	$-473
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-318,294	$-256,724	$-190,528	$-165,967

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$83,155	$75,218	$51,688	$38,626
Debt Securities, Available-for-sale, Current	$365,542	$217,258	$198,522	$293,978
Debt Securities, Available-for-sale, Noncurrent	$0	$80,673	$8,043	$90,986
Prepaid Expense and Other Assets, Current	$10,418	$10,910	$7,539	$7,396
Operating Lease, Right-of-Use Asset	$63,703	$45,205	$39,888	$37,739
Assets, Current	$459,115	$303,386	$257,749	$340,000
Property, Plant and Equipment, Net	$99,478	$86,056	$72,839	$67,382
Escrow Deposit	—	$20,773	$23,479	$0
Restricted Cash, Noncurrent	$10,292	$10,292	$10,292	$10,292
Other Assets, Noncurrent	$6,604	$2,325	$3,615	$3,692
Assets	$642,837	$548,710	$415,905	$550,091
Operating Lease, Liability, Noncurrent	$88,346	$83,247	$75,045	$70,353
Other Liabilities, Noncurrent	$5,179	$7,761	$15,804	$11,836
Liabilities	$130,604	$126,531	$123,363	$113,916
Accounts Payable, Current	$5,897	$5,394	$4,270	$5,964
Liabilities, Current	$37,079	$35,523	$32,514	$31,727
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$169	$212	$229	$345
Additional Paid in Capital, Common Stock	$2,075,252	$2,241,879	$2,302,753	$2,532,341
Retained Earnings (Accumulated Deficit)	$-1,562,233	$-1,819,823	$-2,010,709	$-2,095,993
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-955	$-89	$269	$-518
Stockholders' Equity Attributable to Parent	$512,233	$422,179	$292,542	$436,175
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	400,000,000	400,000,000	400,000,000	800,000,000
Common Stock, Shares, Issued	168,642,238	212,210,597	229,413,523	345,345,427
Property, Plant and Equipment, Gross	$150,562	$148,594	$145,372	$145,364
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$51,084	$62,538	$72,533	$77,982
Depreciation, Depletion and Amortization	$14,200	$13,639	$12,359	$5,514
Property, Plant and Equipment, Disposals	$100	$300	$100	$100
Impairment of Long-Lived Assets Held-for-use	$13,245	$15,717	$2,382	$0
Sublease Income	$22,700	—	—	$22,700
Restructuring Reserve	—	—	$14	$14
InterestExpenseNonoperating	—	$181	$1,075	$643
Restructuring Charges	—	—	$4,746	$4,746
Payments for Restructuring	—	—	$3,227	$3,227
Restructuring Reserve, Accrual Adjustment	—	—	$-1,505	$-1,505
Employee-related Liabilities, Current	$12,665	$12,146	$10,241	$10,241
Other Liabilities, Current	$1,809	$1,072	$2,397	$2,397

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$21,251	$-7,937	$-23,530	$-13,706
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$93,447	$85,510	$61,980	$49,834
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-327,265	$-257,590	$-190,886	$-165,494
Net Cash Provided by (Used in) Operating Activities	$-237,733	$-200,300	$-149,246	$-102,196
Payments to Acquire Property, Plant, and Equipment	$1,516	$694	$386	$402
Proceeds from Sale of Debt Securities, Available-for-sale	$5,623	$5,398	$0	$0
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	$597,811	$432,459	$234,202	$232,329
Payments to Acquire Investments	$438,629	$361,475	$138,257	$363,526
Net Cash Provided by (Used in) Investing Activities	$163,289	$75,688	$95,559	$-131,599
Proceeds from Issuance of Common Stock	$91,112	—	—	—
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$2,087	$813	$0	$4
Proceeds from Stock Plans	$2,496	$1,535	$895	$707
Net Cash Provided by (Used in) Financing Activities	$95,695	$116,675	$30,157	$220,089
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$0	$2,409	$0	$0
Capital Expenditures Incurred but Not yet Paid	$0	$64	$107	$-108
Payments for Leasing Costs, Commissions, and Tenant Improvements	$12,049	$12,505	$12,921	$12,931
Share-based Payment Arrangement, Noncash Expense	$65,951	$51,743	$37,642	$37,492
Depreciation, Depletion and Amortization	$14,200	$13,639	$12,359	$11,668
Investment Income, Net, Amortization of Discount and Premium	$6,809	$8,348	$4,221	$3,942
Impairment of Long-Lived Assets Held-for-use	$13,245	$15,717	$2,382	$0
Equity Method Investment, Other than Temporary Impairment	$7,000	$1,957	$0	$0
Operating Lease, Expense	$642	$5,264	$4,355	$4,227
Income Tax Expense (Benefit)	$0	$443	$0	$0
Income (Loss) from Equity Method Investments	—	$-1,688	$0	$0
Increase (Decrease) in Deposit Assets	—	$20,773	$2,706	$-23,484
Increase (Decrease) in Prepaid Expense and Other Assets	$-1,086	$492	$-3,238	$-2,139
Increase (Decrease) in Other Noncurrent Assets	$1,455	$-4,279	$1,290	$-131
Increase (Decrease) in Accounts Payable	$-7,502	$-503	$-1,231	$1,221
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities	$-6,820	$-1,262	$-2,520	$-1,853
IncreaseDecreaseInOperatingLeaseLiability	—	$-6,307	$-7,503	$-7,989
Increase (Decrease) in Other Noncurrent Liabilities	$-611	$259	$1,135	$1,360

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("ALLO","financials")

Full statements spill as a table. For one cell: =jivedata("ALLO","Revenue") or =jivedata("ALLO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.